New Nano-Film Single-Rivet Patent Ductus Arteriosus Occluders: A Prospective, Randomized and Double-blind Study

Abstract

Nitinol alloy occluders are widely used in the transcatheter intervention treatment of congenital heart diseases like patent ductus arteriosus (PDA). However, nitinol alloy contains high levels of nickel, which can lead to toxic effects in the immune and hematopoietic systems if released in sufficient quantities. A new type of single-rivet occluder coated with nano-film has been developed to limit the release of nickel. In total, 23 patients were recruited and randomly assigned to the experimental group (n=12) with the new nano-film single-rivet occluders or the control group (n=11) with the traditional occluders. One case in the control group was lost to follow-up. The remaining 22 cases were followed up at 24 h, 7 days, 1 month, 3 months, and 6 months after the procedure. There were no statistically significant differences in routine blood test, alanine aminotransferase, creatinine, and troponin between the experimental and control groups. Serum nickel concentration in both two groups increased at 24 h after the procedure, peaked at 1 month, and returned to preoperative levels at 6 months. Serum nickel levels in the experimental group were significantly lower than in the control group at 24 h, 7 days, 1 month, and 3 months after the procedure. These data suggested that the nano-film coating effectively prevented nickel release from the new occluders, and therefore has a preferable safety profile.

Keywords

patent ductus arteriosus / intervention / nitinol alloy / nano-film / nickel ion

References

[1] LiuM, QinC, XiaX, et al.. Senmi-quantitative assessment of pulmonary artery hypertension associated with congenital disease through myocardial perfusion imaging. Hell J Nucl Med, 2017, 20(3): 204-210

[2] MasriS, El RassiI, ArabiM, et al.. Percutaneous closure of patent ductus arteriosus in children using amplatzer duct occluder II: relationship between PDA type and risk of device protrusion into the descending aorta. Catheter Cardiovasc Interv, 2015, 86(2): E66-E72

[3] OnozawaS, MurataS, MineT, et al.. Amplatzer Vascular Plug Anchoring Technique to Stabilize the Delivery System for Microcoil Embolization. Cardiovasc Intervent Radiol, 2016, 39(5): 756-760

[4] SinghHR, TurnerDR, ForbesTJ. Nickel allergy and the amplatzer septal occluder. J Invasive Cardiol, 2004, 16(11): 681-682

[5] TangL, FangZF, TangJJ, et al.. Silent embolization of an atrial septal defect occluder into the right ventricle detected 20 months post-implantation.. Can J Cardiol, 2014, 30(11): 1462.el7-el 8

[6] KongH, GuX, BassJL, et al.. Experimental evaluation of a modified Amplatzer duct occluder. Catheter Cardiovasc Interv, 2001, 53(4): 571-576

[7] WangS, LiuY, OuyangW, et al.. Application research of percutaneous patent ductus arteriosus closure by femoral vein approach under echocardiography guidance. Zhonghua Yi Xue Za Zhi (Chinese), 2015, 95(27): 2183-2185

[8] YangF, ZhengH, LyuJ, et al.. A case of transcatheter closure of inferior vena cava type atrial septal defect with patent ductus arteriosus occlusion device guided by 3D printing technology. Zhonghua Xin Xue Guan Bing Za Zhi (Chinese), 2015, 43(7): 631-633

[9] WangY, CaoHY, XieMX, et al.. Cardiovascular cast model fabrication and casting effectiveness evaluation in fetus with severe congenital heart disease or normal heart. J Huazhong Univ Sei Technolog Med Sei, 2016, 36(2): 259-264

[10] MasuraJ, GavoraP, FormanekA, et al.. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn, 1997, 42(4): 388-393

[11] GoodmanJE, PrueittRL, DodgeDG, et al.. Carcinogenicity assessment of water-soluble nickel compounds. Crit Rev Toxicol, 2009, 39(5): 365-417

[12] RyhänenJ, KallioinenM, TuukkanenJ, et al.. In vivo biocompatibility evaluation of nickel-titanium shape memory metal alloy: muscle and perineural tissue responses and encapsule membrane thickness. J Biomed Mater Res, 1998, 41(3): 481-488

[13] ZhaoX, ZhuZA, SunYH, et al.. Nickel-titanium shape-memory sawtooth-arm embracing fixator for periprosthetic femoral fractures. Int Orthop, 2012, 36(3): 619-626

[14] XuY, LiC, ZhouT, et al.. Treatment of Aseptic Necrosis of the Lunate Bone (Kienböck Disease) Using a Nickel-Titanium Memory Alloy Arthrodesis Concentrator: A Series of 24 Cases. Medicine (Baltimore), 2015, 94(42): el760

[15] LiH, MaoY, QuX, et al.. Nickel-Titanium Shape-Memory Sawtooth-Arm Embracing Clamp for Complex Femoral Revision Hip Arthroplasty. J Arthroplasty, 2016, 31(4): 850-856

[16] McMahonRE, MaJ, VerkhoturovSV, et al.. A comparative study of the cytotoxicity and corrosion resistance of nickel-titanium and titanium-niobium shape memory alloys. Acta Biomater, 2012, 8(7): 2863-2870

[17] BurianM, NeumannT, WeberM, et al.. Nickel release, a possible indicator for the duration of antiplatelet treatment, from a nickel cardiac device in vivo: a study in patients with atrial septal defects implanted with an Amplatzer occluder. Int J Clin Pharmacol Ther, 2006, 44(3): 107-112

[18] ChoiDY, KimNY, JungMJ, et al.. The results of transcatheter occlusion of patent ductus arteriosus: success rate and complications over 12 years in a single center.. Korean Circ J, 2010, 40(5): 230-234